D. Western Therapeutics Institute Inc. Company Profile

Health Care & Life Sciences » Biotechnology | D. Western Therapeutics Institute Inc.

D. Western Therapeutics Institute Inc.

D. Western Therapeutics Institute Inc.
Stock Exchange	Tokyo Stock Exchange
EPS	JPY23.07
Market Cap	JPY11.69 B
Shares Outstanding	26.28 M
Public Float	18.87 M

Address	CK21 Hirokoji-Fushimi Building, 7/F Nagoya Aichi 460 Japan
Employees	-
Website	http://www.dwti.co.jp
Updated	09/14/2018
D. Western Therapeutics Institute, Inc. engages in the research and development of pharmaceutical drugs. Its products include ophthalmic solution and agents for anti-platelet and anti-glaucoma.

Tetsuya Kawakami

Director, Manager-Administration & General Affairs

Eisaku Nakamura

Outside Director